樂觀
$0.77
情境價格
$5.139
+1.194 (+23.24%)收盤時
OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets.
Onemednet Corp appears to be a good buy right now due to its recent significant revenue growth of 242% from Q2 2026 and a strong 21.78% increase in stock price over the last five days. However, the company still faces risks with a current ratio of only 0.28, indicating potential liquidity issues.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

OneMedNet Reports Significant Revenue Growth in Q3

Atropos Health Expands Data Network for Enhanced Clinical Insights

OneMedNet Partners with AI Drug Development Firm for Real-World Data

OneMedNet Enters Agreement for AI Model Development

OneMedNet Signs $11.5 Million Agreement for AI Model Data Supply
OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets. It operates in the Industrials sector (COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH industry).
Onemednet Corp appears to be a good buy right now due to its recent significant revenue growth of 242% from Q2 2026 and a strong 21.78% increase in stock price over the last five days. However, the company still faces risks with a current ratio of only 0.28, indicating potential liquidity issues.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。